Brief: Diagonal Bio Says Board Decides On Preferential Rights Issue Of Units
28/02/2024 16:42
Feb 28 (Reuters) - Diagonal Bio AB DIABIO.ST :
* BOARD OF DIRECTORS DECIDES ON A PREFERENTIAL RIGHTS ISSUE
OF
UNITS IN ORDER TO FINANCE FUTURE DEVELOPMENT
* ISSUE VOLUME INITIALLY AMOUNTS TO A MAXIMUM OF
APPROXIMATELY SEK
32 MILLION BEFORE TRANSACTION RELATED COSTS
* DIAGONAL BIO HAS ALSO RAISED A BRIDGE LOAN OF
APPROXIMATELY SEK
4 MILLION
Source text for Eikon: ID:nWkr2g5JNW
Further company coverage: DIABIO.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Diagonal Bio AB
See all newsBrief: Diagonal Bio Approved For Delisting From Nasdaq First NGM
Brief: Diagonal Bio Gets Conditional Approval For Listing On NGM Nordic SME
Brief: Diagonal Bio Applies For Change Of Marketplace To NGM Nordic SME
Brief: Diagonal Bio Resolves On Directed Issue Of Units To All External Underwriters
Brief: Diagonal Bio Says Positive Pilot Test Results, Gets Order From Stallzet